University of Rochester: Heart Failure trials
The registry lists 12 Heart Failure studies with University of Rochester as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 2 1Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorRecruitingNCT06964464Phase 4
- Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter DefibrillatorRecruitingNCT06543173Not applicable
- His-Bundle Corrective Pacing in Heart FailureRecruitingNCT05265520Not applicable
- OptiVol for Precision Medical Management of Heart FailureTerminatedNCT04206501Not applicableResults posted
- Ranolazine Implantable Cardioverter-Defibrillator TrialCompletedNCT01215253Phase 3Results posted
- Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG PatternActive, not recruitingNCT06977217
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure PatientsActive, not recruitingNCT04818645Not applicable
- A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital ReadmissionsTerminatedNCT04550052
- Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection FractionTerminatedNCT04327596Not applicable
- EMPOWER Study, a Personalized Home Care Intervention for Older Heart Failure PatientsWithdrawnNCT03971149Not applicable
- Problem-solving to Improve Depressive Symptoms and Self- Care Among Recently Hospitalized Adults With Heart FailureWithdrawnNCT03606304Not applicable
- Nesiritide and Vo2 Max in Heart Failure PatientsCompletedNCT00240084Phase 2